Comparative effects of diaphragmatic myofascial release versus diaphragmatic breathing in post operative patients diagnosed with Gastroesophaegeal reflux disease (GERD)
Not Applicable
Recruiting
- Conditions
- Gastroesophaegeal reflux disease.Gastroesophaegeal reflux diseaseGastroesop
- Registration Number
- IRCT20240731062603N1
- Lead Sponsor
- Self
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
Both genders,age 25 to 45 years
Willingness to participate
Participants with stable cardiovascular and respiratory system
Confirmed diagnosis of GERD 1 week after surgery
Exclusion Criteria
Diagnosed Febrile illness
Diagnosed malignancy
Diagnosed psychiatric disorder
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link diaphragmatic myofascial release to GERD symptom reduction post-surgery?
How does diaphragmatic breathing compare to standard-of-care therapies for post-operative GERD management?
Are there specific biomarkers that predict better outcomes with diaphragmatic myofascial release in GERD patients?
What are the potential adverse events associated with diaphragmatic myofascial release in post-surgical GERD patients?
How do diaphragmatic interventions influence lower esophageal sphincter pressure and GERD recurrence rates post-surgery?